NEW YORK (GenomeWeb) – Synthego — a Bay Area-based biotech startup aiming to automate and scale up genome engineering research — today announced it has raised $41 million in a Series B financing round.

AME Cloud Ventures, Elements Capital, OS Fund, Alexandria Equities, ZhenFund, and University of California, Berkeley CRISPR researcher Jennifer Doudna joined the round as new investors, which was led by venture capital firm 8VC. Existing investors Founders Fund, Menlo Ventures, WI Harper Group, and SciFi VC also participated.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.